DCF — CLARA MAASS MEDICAL CENTER
Enterprise Value: $-224.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-224.9M
Enterprise Value
$-78.9M
PV of Cash Flows
$-146.0M
PV of Terminal Value
$-235.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $371.0M | $-9.8M | -3.0% | $-25.5M | $-23.2M |
| Year 2 | $382.1M | $-6.3M | -2.0% | $-22.4M | $-18.5M |
| Year 3 | $393.6M | $-2.5M | -1.0% | $-19.2M | $-14.4M |
| Year 4 | $405.4M | $-0.6M | -0.0% | $-17.7M | $-12.1M |
| Year 5 | $417.5M | $0.5M | 0.0% | $-17.2M | $-10.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-224.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$360.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03136973542029828
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5